HOME >> BIOLOGY >> NEWS
Vanderbilt doctors find citrus soda interacts with cyclosporine, maybe statins

Bill Turner, 35, never knew that drinking a popular beverage could send his recovery from a double-lung transplant on a mysterious roller coaster ride.

It took a team of medical sleuths at Vanderbilt University Medical Center to discover that the wild up-and-down swings in levels of the anti-rejection drug cyclosporine were fueled by the Sun Drop soft drink Turner drank to quench his caffeine cravings. Solving the case identified a new food-and-drug interaction that could be harmful for all transplant patients, and, possibly, people taking a class of anti-cholesterol drugs called statins.

During a clinic visit to Aaron Milstone, M.D., assistant professor of Medicine and medical director of Vanderbilt's Lung Transplant Program, Turner's blood was drawn to monitor, among other things, the serum levels of the drug cyclosporine, which kept his body from rejecting his new organs. The levels, previously normal, were more than double the suggested concentration, creating the potential for drug toxicity and serious side effects, such as kidney damage or central nervous system damage.

The question was, why.

Milstone and transplant coordinator Haley Hoy questioned Turner extensively about the possibility of altered cyclosporine doses or any other changes in his new medical routine. Turner said he felt fatigued and was experiencing nervous tremors, but had done nothing different.

Turner was tested again two days later and his cyclosporine serum levels were well within therapeutic limits. This pattern repeated itself again at the next month's clinic visit: the cyclosporine levels were more than twice the accepted level on the day of the clinic visit, but then normal again upon retesting two days later.

"After this process of high and normal levels repeated itself, we began a dietary inquiry," Milstone said. "Is there something in Bill's diet that was doing this?"

Milstone says all transplant patients are counseled not to c
'"/>

Contact: John Howser
john.howser@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
15-Apr-2004


Page: 1 2 3

Related biology news :

1. Vanderbilt students take HHMI fellowships
2. Vanderbilts John Oates wins clinical research award
3. Vanderbilt doctors use Viagra to treat infants with pulmonary hyptertension
4. Vanderbilt researchers receive fellowships to support early identification, genetic causes of autism
5. Vanderbilt, Meharry establish new Center for AIDS Research
6. Researchers at Vanderbilts Free-Electron Laser Center are developing new forms of laser surgery, improved X-ray technology, and better methods for protein identification
7. National Cancer Institute designates Vanderbilt-Ingram a Comprehensive Cancer Center
8. Vanderbilt neuroscientists identify oops center in the brain
9. Procter & Gamble donates proprietary "super aspirin" technology to Vanderbilt University
10. Vanderbilt archaeological team unearths buried Maya royal palace
11. Matrisian named Vanderbilts first chair of cancer biology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2020)... ... June 25, 2020 , ... ... R&D, today announced that it has entered into a multi-year contract with ... to support their translational and clinical research strategy to discover and develop ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC , ... that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) ... with severe COVID-19. This is the first study of an XPO1 inhibitor in ...
(Date:6/23/2020)... ... June 23, 2020 , ... First Aid Africa, ... a UK supplier and manufacturer of innovative portable renewable energy equipment, have announced ... fight against the COVID-19 pandemic in Zambia. , One of Renovagen’s FAST FOLD ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... ... “We are thrilled to deliver this new technology to the industry” said ... on the market and we were pleased that the IFT jury recognized that.” reFRESH™ ... creating a natural way to extend the shelf life and improve the safety of ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors Inc., ... has expanded the company’s exclusive license to include clinical applications for CANARY™ ... market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly ...
(Date:7/7/2020)... ... July 06, 2020 , ... ... Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General ... World has hosted an elite awards program, highlighting outstanding examples of how technology ...
(Date:6/28/2020)... ... ... The Indoor Lab, a leading provider of sensor solutions for monitoring foot ... ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ technology using Artificial Intelligence ... a health performance index system that scores all aspects of compliance similar to the ...
Breaking Biology Technology:
Cached News: